By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

aTyr Pharma Inc. 

10685 Road to the Cure
Suite 100
San Diego  California  92121  U.S.A.
Phone: 858-731-8389 Fax: 858-731-8394


SEARCH JOBS


Industry
Pharmaceutical

Segment
Start Up





Company News
aTyr Pharma Announces First Quarter 2017 Operating Results 5/12/2017 11:13:26 AM
aTyr Pharma Presents Analyses Of Resolaris Phase Ib/II Trial In Patients With Limb Girdle Muscular Dystrophy 2B And Facioscapulohumeral Muscular Dystrophy At American Academy of Neurology 69th Annual Meeting 4/24/2017 11:48:48 AM
aTyr Pharma Announces Promising Top-Line Results From Resolaris Phase Ib/II Clinical Trial in Patients With Early Onset Facioscapulohumeral Muscular Dystrophy 4/24/2017 11:44:33 AM
aTyr Pharma Announces Promising Top-Line Results From Resolaris Phase Ib/II Clinical Trial In Patients With Early Onset Facioscapulohumeral Muscular Dystrophy 4/24/2017 10:29:55 AM
aTyr Pharma Presents Analyses Of Resolaris Phase Ib/II Trial In Patients With Limb Girdle Muscular Dystrophy 2B And Facioscapulohumeral Muscular Dystrophy At The American Academy of Neurology 69th Annual Meeting 4/24/2017 10:22:49 AM
aTyr Pharma Announces Appointment Of Timothy P. Coughlin To Its Board Of Directors 4/11/2017 10:37:28 AM
aTyr Pharma Announces Appointment Of Timothy P. Coughlin To Its Board Of Directors 4/11/2017 10:25:46 AM
aTyr Pharma Announces Appointment Of Jeffery S. Hatfield To Its Board Of Directors 4/3/2017 11:47:30 AM
aTyr Pharma Announces Fourth Quarter And Year-End 2016 Operating Results 3/17/2017 11:11:07 AM
aTyr Pharma Announces Issuance Of U.S. Patent That Extends Patent Protection Of Physiocrines Derived From 20 Out Of 20 Human tRNA Synthetases 3/15/2017 6:30:08 AM
123456789
//-->